Home/Filings/4/0001144204-18-014639
4//SEC Filing

Longcor Jarrod 4

Accession 0001144204-18-014639

CIK 0001279704other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 4:01 PM ET

Size

5.6 KB

Accession

0001144204-18-014639

Insider Transaction Report

Form 4
Period: 2018-03-13
Longcor Jarrod
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2018-03-13$1.18/sh13,000$15,39767,000 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2017 to satisfy tax withholding obligations upon vesting of restricted stock.
  • [F2]The price reported in Column 4 of Line 1 with respect to the 13,000 shares sold on March 13, 2018 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.17 to $1.21. The Reporting Person has provided to the Issuer, and undertakes to provide to any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnote (2) to this Form 4.

Issuer

Cellectar Biosciences, Inc.

CIK 0001279704

Entity typeother

Related Parties

1
  • filerCIK 0001545565

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:01 PM ET
Size
5.6 KB